CIPROFLOXACIN INJECTION USP
CIPROFLOXACIN INJECTION USP
Discontinued
DIN Number
02301903
Drug Class
Human
Market Date
Apr 8, 2008
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02301903
AIG Number0123207007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01MA02 CIPROFLOXACIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification08:12.18
Health Canada Classification
ACTIVE INGREDIENTS (1)
CIPROFLOXACINActive
Strength: 2 MG / ML
Monograph: CIPROFLOXACIN